4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-16-111161
Options or other derivatives
- VP, Clinical Affairs acquired 21,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Blackburn Kelly VP, Clinical Affairs | 2016-03-28 | Grant or award · Restricted Stock Unit | +21,600 | 21,600 | D | ||
Loading xslF345X03/doc4.xml…